If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEXO.L Regulatory News (EXO)

  • There is currently no data for EXO

Exova opens Pittsburgh laboratory

13 Oct 2015 14:00

RNS Number : 0736C
Exova Group PLC
13 October 2015
 

 

 

13 October 2015

 

Exova opens Pittsburgh laboratory

 

Exova, the global testing group, has opened its first facility in the North East of the US with a new materials and corrosion testing laboratory in Pittsburgh.

 

The laboratory will provide testing and consultancy services in metallurgy, polymers and coatings as well as corrosion risk assessment and mitigation, primarily to the oil & gas and industrials sectors.

The location of the laboratory close to the Marcellus shale field brings Exova's services to an important region by providing particular expertise in supporting field inspection and corrosion mitigation.

 

The laboratory also extends the company's advisory services in areas including failure analysis and risk assessment. Combining with Exova's existing global capabilities, the specialist team in Pittsburgh will work with customers to improve the performance and quality to their in-service assets.

 

The new facility, under the operational leadership of General Manager, John Ciliege, and technical leadership of Dr Mehrooz Zamanzadeh, will be part of Exova's oil and gas division in the US and will also work closely with the company's network of oil & gas, aerospace and industrials laboratories worldwide.

 

Gary Brimmage, President of Exova in the Americas comments: "This new investment underlines our commitment to being at the forefront of industrial materials and corrosion solutions. Offering both testing and advisory capabilities we are able to support our customers throughout the entire life cycle of oil and gas and industrial assets, helping them to meet their technical and commercial needs."

 

The Pittsburgh laboratory represents Exova's 143rd facility in 32 countries worldwide.

 

 

 

 

All media enquiries, please contact:

 

Stuart Neill, Group Communications Manager, Exova

Tel. +44 131 335 4371 / +44 7799 365 043

E: stuart.neill@exova.com

 

Angela Casey

Pagoda Porter Novelli

T: +44 131 556 0770

E: angela.casey@pagodapr.com

 

Ian Middleton or Samantha Trillwood

Powerscourt

T: +44 (0)20 7250 1446

E: exova@powerscourt-group.com

 

Exova

 

Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK, Exova operates 143 laboratories and offices in 32 countries and employs around 4,500 people throughout Europe, the Americas, the Middle East and Asia/Asia Pacific.

 

Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors from health sciences to aerospace, transportation, oil and gas, fire and construction.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGGGAUUUPAUBW
Date   Source Headline
28th Mar 201711:45 amRNSForm 8.5 (EPT/RI) Exova Group Plc
28th Mar 201711:16 amRNSForm 8.5 (EPT/RI)
28th Mar 201711:00 amRNSForm 8.5 (EPT/RI)
28th Mar 201710:33 amRNSForm 8.3 - Exova Group plc
28th Mar 20177:00 amBUSForm 8.3 - Exova Group Plc
27th Mar 20173:12 pmBUSForm 8.3 - Exova Group Plc
27th Mar 20173:05 pmRNSForm 8.3 - Exova Group Plc
27th Mar 201710:37 amRNSForm 8.3 - Exova Group PLC
27th Mar 20179:15 amRNSRule 2.9 Announcement
27th Mar 20177:00 amRNSPossible Offer for Exova Group plc
28th Feb 20177:00 amRNSFinal Results
12th Jan 20177:00 amRNSPost-close Trading Update
21st Dec 201612:06 pmRNSChanges to Nomination Committee
6th Dec 20167:02 amRNSDevelopment of global laboratory portfolio
1st Dec 20163:15 pmRNSVoting Rights and Capital
29th Nov 20169:00 amRNSDirector/PDMR Shareholding
24th Nov 20169:00 amRNSIssue of Equity
24th Nov 20169:00 amRNSDirector/PDMR Shareholding
24th Nov 20167:00 amRNSDivisional Reporting of Historic Results
24th Nov 20167:00 amRNSTrading Statement
27th Oct 20164:35 pmRNSPrice Monitoring Extension
24th Oct 20168:51 amRNSTR-1: Notification of Major Interest in Shares
21st Oct 20169:27 amRNSTR-1: Notification of Major Interest in Shares
4th Oct 20164:35 pmRNSPrice Monitoring Extension
21st Sep 20167:00 amRNS2016 Capital Markets Day
13th Sep 20169:00 amRNSTR-1: Notification of Major Interest in Shares
31st Aug 20167:00 amRNSHalf-year Report
21st Jul 20164:40 pmRNSSecond Price Monitoring Extn
21st Jul 20164:35 pmRNSPrice Monitoring Extension
4th Jul 20167:00 amRNSExova acquires Jones Environmental Forensics
1st Jul 20167:00 amRNSExova completes sale of Food, Water & Pharma Biz
29th Jun 20163:07 pmRNSNotice of Results and Capital Markets Day
28th Jun 20164:40 pmRNSSecond Price Monitoring Extn
28th Jun 20164:35 pmRNSPrice Monitoring Extension
1st Jun 20168:00 amRNSDirector Declaration
19th May 20161:46 pmRNSResult of AGM
19th May 20161:39 pmRNSAGM Statement
19th May 20167:00 amRNSExova sells UK & Ire Food, Water & Pharma Business
19th May 20167:00 amRNSTrading Update
10th May 20169:00 amRNSDirector/PDMR Shareholding
5th May 201610:00 amRNSIssue of Equity
5th May 201610:00 amRNSDirector/PDMR Shareholding
22nd Apr 20162:00 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
19th Apr 20162:00 pmRNSDirector/PDMR Shareholding
11th Apr 20169:43 amRNSAnnual Report & Accounts 2015 & Notice of 2016 AGM
1st Apr 20169:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
9th Mar 20169:00 amRNSDirector/PDMR Shareholding
7th Mar 20169:00 amRNSDirector/PDMR Shareholding
3rd Mar 20167:00 amRNSFinal Results
18th Feb 201610:16 amRNSDisclosure of Home Member State

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.